ASMB
Assembly Biosciences Inc
22.20$
-2.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +244.7% | +12.7% | +24.7% | +7.5% | -9.7% | +33.2% | -12.8% | +4.0% | -20.7% | +37.4% | +12.6% | -14.4% | +864.9% | -12.1% | -97.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | – | – | -19.2% | +47.5% | -19.8% | +7.5% | +28.0% | +2.2% | +12.1% | +293.6% | -80.7% | +62.8% | – | |
| – | -2.4% | +22.6% | +14.7% | -9.9% | -3.0% | +37.2% | +22.7% | +7.1% | +11.2% | +6.8% | -17.6% | +16.2% | +2.1% | +3.9% | +1.2% | +15.5% | +4.0% | -33.8% | -9.7% | +10.3% | -33.6% | +40.2% | +0.5% | +0.8% | -1.0% | -15.7% | -13.9% | -13.6% | -99.2% | -61.9% | +0.0% | +42,134.4% | +5.7% | +4.0% | +8.6% | +2.9% | -99.8% | -18.8% | -23.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -52.2% | -451.8% | – | – | – | – | – | – | – | – | – | – | – | – | -18.7% | +47.8% | -178.5% | – | – | – | – | – | -80.7% | +63.1% | – | |
| – | -2.4% | +22.6% | +14.7% | -9.9% | -3.0% | +37.2% | +22.7% | +7.1% | +11.2% | +6.8% | -17.6% | +16.2% | +4.0% | +1.9% | +1.2% | +15.5% | +24.4% | -48.7% | -2.7% | +10.3% | -20.2% | +16.7% | +3.4% | +1.9% | -7.0% | -13.7% | -13.9% | -13.6% | +1.7% | +7.9% | +36.9% | -16.9% | +5.7% | +4.0% | +8.6% | +2.9% | +4.0% | -13.6% | +0.1% | – | |
| – | +14.1% | +24.5% | -5.9% | +10.0% | +19.6% | +14.0% | +120.2% | -38.2% | +13.6% | +8.1% | -57.1% | +108.0% | +8.1% | -4.8% | +8.5% | +23.4% | -40.4% | +24.8% | -20.5% | -3.8% | -6.4% | -4.3% | +5.4% | -17.7% | +24.3% | -22.0% | -0.9% | -14.9% | +106.2% | -46.8% | -3.4% | -4.3% | +7.5% | -2.2% | +1.9% | +10.7% | +6.6% | -13.6% | +2.5% | – | |
| – | +1.6% | +23.1% | +9.0% | -5.1% | +3.2% | +29.8% | +50.1% | -11.6% | +11.9% | +7.2% | -29.3% | +32.7% | -62.7% | -22.5% | +8.5% | +23.4% | +8.3% | -31.2% | -20.5% | -3.8% | +660.6% | -88.2% | +22.2% | -18.0% | -4.1% | -12.5% | -0.9% | -14.9% | +364.7% | -16.0% | +25.6% | -79.3% | +7.5% | -2.2% | +1.9% | +10.7% | +345.8% | -13.6% | +0.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -161.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -157.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -33.5% | -3.0% | -66.6% | -74.1% | +22.4% | +1.4% | +40.3% | -29.7% | +57.7% | +128.6% | +71.5% | +38.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -146.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -141.1% | – | – | |
| – | – | – | -9,198.6% | – | – | – | – | – | – | -100.6% | – | – | – | -115.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,063.0% | – | -134.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -146.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -141.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -157.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -140.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.